NewBay Pharma
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An anti-infectives company developing novel small molecule antibiotics to fight drug-resistant bacteria.
Infectious Disease
Technology Platform
A discovery platform focused on identifying novel small molecule antibiotics with new mechanisms of action to overcome bacterial resistance.
Opportunities
Addressing a critical global health threat with support from government and non-profit push-pull incentives for novel antibiotics.
Risk Factors
Severe commercial market failure for antibiotics poses existential financial risk, despite the high clinical need.
Competitive Landscape
Operates in a high-need but financially challenging antibiotic development sector with limited competitors but also limited commercial incentives.